Medical Journals

Passive Immunotherapy of Bacillus Anthracis Pulmonary Infection in Mice with Antisera Produced by Dna Immunization.

Authors:
  • Herrmann John E
  • Wang Shixia
  • Zhang Chuanyou
  • Panchal Rekha G
  • Bavari Sina
  • Lyons C Rick
  • Lovchik Julie A
  • Golding Basil
  • Shiloach Joseph
  • Lu Shan

From: Antibody Science, Inc., 80 Webster Street, Worcester, MA 01603, USAASI@AbScience.com

Vaccine

  • Publish Date: Jul 2006
  • ISSN: 0264-410X
  • Volume: 24
  • Issue: 31-32
  • Pages: 5872-80
  • Medium: Print
  • Language: English
  • Citation (JAMA): Herrmann John E, Wang Shixia, Zhang Chuanyou, et al. Passive Immunotherapy of Bacillus Anthracis Pulmonary Infection in Mice with Antisera Produced by Dna Immunization.. Vaccine Jul 2006;24:5872-80

Abstract

Because of the high failure rate of antibiotic treatment in patients with anthrax there is a need for additional therapies such as passive immunization with therapeutic antibodies. In this study, we used codon-optimized plasmid DNAs (DNA vaccines) encoding Bacillus anthracis protective antigen (PA) to immunize rabbits for producing anti-anthrax antibodies for use in passive immunotherapy. The antisera generated with these DNA vaccines were of high titer as measured by ELISA. The antisera were also able to protect J774 macrophage cells by neutralizing the cytotoxic effect of exogenously added anthrax lethal toxin, and of the toxin released by B. anthracis (Sterne strain) spores following infection. In addition, the antisera passively protected mice against pulmonary challenge with an approximate 50 LD50 dose of B. anthracis (Sterne strain) spores. The protection in mice was obtained when the antiserum was given 1h before or 1h after challenge. We further demonstrated that IgG and F(ab’)2 components purified from anti-PA rabbit hyperimmune sera retained similar levels of neutralizing activities against both exogenously added B. anthracis lethal toxin and toxin produced by B. anthracis (Sterne strain) spores. The high titer antisera we produced will enable an immunization strategy to supplement antibiotic therapy for improving the survival of patients with anthrax.

Mesh Headings (Keywords): Animals, Anthrax, Anthrax Vaccines, Bacillus anthracis, Female, Immune Sera, Immunization, Passive, Mice, Mice, Inbred DBA, Pneumonia, Bacterial, Rabbits, Vaccines, DNA


Check for Full Text / PubMed Unique Identifier (PMID): 16790303


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.